Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
Dinali H Fernando, Josephine M Forbes, Peter W Angus, Chandana B Herath
International Journal of Molecular Sciences | MDPI | Published : 2019
Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the adult population and is now a major cause of liver disease-related premature illness and deaths in the world. Treatment is largely based on lifestyle modification, which is difficult to achieve in most patients. Progression of simple fatty liver or steatosis to its severe form non-alcoholic steatohepatitis (NASH) and liver fibrosis has been explained by a 'two-hit hypothesis'. Whilst simple steatosis is considered the first hit, its transformation to NASH may be driven by a second hit. Of several factors that constitute the second hit, advanced glycation end products (AGEs), which are formed when reducing-sugars react with pr..View full abstract
Related Projects (1)
Awarded by National Health and Medical Research Council (NHMRC) of Australia
This work was supported by National Health and Medical Research Council (NHMRC) of Australia project grant (APP1029990).